Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30,192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimized submerged batch fermentation for metabolic switching in Streptomyces yanglinensis 3-10 providing platform for reveromycin A and B biosynthesis, engineering, and production.
Yang L, Shakeel Q, Xu X, Ali L, Chen Z, Mubeen M, Sohail MA, IfItikhar Y, Kumar A, Solanki MK, Zhou Y, Zhao D, Alharbi NK, Wang J. Yang L, et al. Among authors: kumar a. Front Microbiol. 2024 May 7;15:1378834. doi: 10.3389/fmicb.2024.1378834. eCollection 2024. Front Microbiol. 2024. PMID: 38784807 Free PMC article.
Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program.
Salvetti M, Wray S, Nelles G, Belviso N, Kumar A, Koster T, Castro-Borrero W, Vignos M; POP Investigators. Salvetti M, et al. Among authors: kumar a. Mult Scler J Exp Transl Clin. 2024 May 23;10(2):20552173241238632. doi: 10.1177/20552173241238632. eCollection 2024 Apr-Jun. Mult Scler J Exp Transl Clin. 2024. PMID: 38784791 Free PMC article.
Efficacy of intrathecal mesenchymal stem cell-neural progenitor therapy in progressive MS: results from a phase II, randomized, placebo-controlled clinical trial.
Harris VK, Stark J, Williams A, Roche M, Malin M, Kumar A, Carlson AL, Kizilbash C, Wollowitz J, Andy C, Gerber LM, Sadiq SA. Harris VK, et al. Among authors: kumar a. Stem Cell Res Ther. 2024 May 23;15(1):151. doi: 10.1186/s13287-024-03765-6. Stem Cell Res Ther. 2024. PMID: 38783390 Clinical Trial.
TET activity safeguards pluripotency throughout embryonic dormancy.
Stötzel M, Cheng CY, IIik IA, Kumar AS, Omgba PA, van der Weijden VA, Zhang Y, Vingron M, Meissner A, Aktaş T, Kretzmer H, Bulut-Karslioğlu A. Stötzel M, et al. Among authors: kumar as. Nat Struct Mol Biol. 2024 May 23. doi: 10.1038/s41594-024-01313-7. Online ahead of print. Nat Struct Mol Biol. 2024. PMID: 38783076
TORC: latest addition to the K+ signaling league.
Bheri M, Kumar A, Pandey GK. Bheri M, et al. Among authors: kumar a. Trends Plant Sci. 2024 May 22:S1360-1385(24)00120-1. doi: 10.1016/j.tplants.2024.05.002. Online ahead of print. Trends Plant Sci. 2024. PMID: 38782620
30,192 results
You have reached the last available page of results. Please see the User Guide for more information.